Holte, Denmark

Anne Charlotte Arentsen

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Novo Nordisk Healthcare Ag, Novo Nordisk A/s. Active years: 2005-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne Charlotte Arentsen. Retrieved from https://idiyas.com/inventor/anne-charlotte-arentsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3

 

Average Co-Inventor Count = 1.8

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2005-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Anne Charlotte Arentsen

Introduction

Anne Charlotte Arentsen is a notable inventor based in Holte, Denmark. She has made significant contributions to the field of biochemistry, particularly in the development of vitamin K-dependent protein compositions. With a total of 3 patents, her work has implications for medical and healthcare applications.

Latest Patents

One of her latest patents focuses on the reduction of protein contaminants in vitamin K-dependent protein compositions. This invention is crucial for preparing compositions of coagulation factors, such as Factor X, Factor IX, and Factor VII polypeptides, as well as the anticoagulant Protein C. Another significant patent involves a closed container that holds an activated Factor VII polypeptide, detailing processes for its preparation and methods for using the kit. These innovations highlight her commitment to improving healthcare solutions.

Career Highlights

Anne has worked with prominent companies in the healthcare sector, including Novo Nordisk Healthcare AG and Novo Nordisk A/S. Her experience in these organizations has allowed her to develop and refine her inventions, contributing to advancements in medical treatments.

Collaborations

Throughout her career, Anne has collaborated with esteemed colleagues such as Janus Krarup and Thomas Budde Hansen. These partnerships have fostered a collaborative environment that enhances innovation and research.

Conclusion

Anne Charlotte Arentsen's contributions to the field of biochemistry through her patents and collaborations demonstrate her dedication to advancing healthcare solutions. Her work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…